CClinicalTrials.gg
Not yet recruitingNCT06719297CMUpdated Dec 5, 2024

Cognitive Integrated Motor Training (CM) to Improve Gait and Balance and Reduce Falls in Older Adults With Mild Cognitive Impairment

An interventional study of Personalized cognitive-sensorimotor VR/MR training and Standard of Care in Mild Cognitive Impairment, sponsored by Kessler Foundation. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by Kessler Foundation · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

Problems with walking and balance are common in older adults with mild cognitive impairment. Walking and balance problems limit independence and increase risk for injuries due to falls. The purpose of this research study is to test the effectiveness of training that combines moving and thinking tasks, referred to as Personalized cognitive integrated sensorimotor virtual reality (VR)/mixed reality (MR) training on walking and balance ability. The study will also help to understand the changes in thinking ability and brain activity as a result of this training in older adults with mild cognitive impairment.

The study will evaluate the differences between two intervention groups (n=20 each): 1) personalized cognitive integrated sensorimotor VR/MR training (CM), and 3) standard of care (CTRL) on gait, balance, community ambulation, and cognitive functions, as well as underlying biomechanical and neurophysiological mechanisms to understand the changes due to CM.

02

Conditions studied

  • Mild Cognitive Impairment

Keywords

  • older adults, mild cognitive impairment, gait, balance
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 40 is below the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Kessler Foundation is the lead sponsor of 170 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Between the age of 65 and 85 years for older adults.
  • Montreal Cognitive Assessment (MOCA), 17 \< MOCA \< 24
  • Medical clearance will be obtained from my clinician. If participants physician is unavailable the study team clinician will provide the medical clearance.
  • Adequate cognitive function to give informed consent, understand the training and instructions, use the device and give adequate feedback.
  • Able to stand for 5 minutes.

Exclusion criteria

Exclusion Criteria:

  • Body weight over 135 kgs.
  • Uncontrolled or unstable seizure disorder.
  • Severe joint contracture or spasticity of the ankle that limits passive range of motion as determined by the team.
  • History of severe cardiac diseases such as myocardial infarction, coronary artery disease, cardiac arrhythmia, or congestive heart failure.
  • Neuromuscular or neurological pathologies (e.g., spinal cord injury, stroke) that will interfere with ambulation.
  • Uncontrolled or unstable orthostatic hypotension.
  • Pre-existing conditions resulting in significant disruption in alignment or function of the lower limb during standing.
  • History of injury or pathology to the lower limbs in the past 6 months or any medical issue precludes full weight-bearing and ambulation (e.g., orthopedic injuries).
  • Diplopia or nystagmus.
  • Walking speed from 10MWT >0.8m/s.

MRI specific exclusion criteria:

  • Medications such as: steroids, benzodiazepines, and neuroleptics. The study doctor will review the medications with the participant.
  • clip to repair a cerebral aneurysm (broken blood vessel in the head), cardiac pace-maker, cochlear implants (internal hearing aids) or metal fragments or pieces in the eyes or any other part of the body.
  • non MRI compatible metal in any part of the body.
  • Medical clearance from a physician that it is medically unsafe to receive regular MRI.
  • Engage in the professions of painting or welding or other occupation that prevents me from getting a regular MRI.
  • claustrophobia (fear of enclosed spaces).
  • History of schizophrenia or bipolar disorder.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Personalized cognitive-sensorimotor VR/MR training

    Thinking task integrated walking and balance training program

    Other: Personalized cognitive-sensorimotor VR/MR training

  • Active comparator
    Standard of Care

    Standard walking and balance training

    Other: Standard of Care

Interventions

  • OtherPersonalized cognitive-sensorimotor VR/MR training

    Thinking task integrated walking and balance training program

  • OtherStandard of Care

    Standard walking and balance training

06

What researchers measure

Primary outcomes

  1. Timed Up and Go (TUG)

    TUG is a clinical test of functional gait abilities and dynamic balance. The participants will be asked to walk a distance of 3 meters from a seated position, turn around, walk back to the chair and sit back in the chair. The time taken to perform the task will be recorded using a stop watch. The TUG will be repeated multiple times. The participant may be asked to hold a plastic cup or count backwards by three from a randomly selected number while walking.

    Time frame: 10 weeks

  2. 10 Meter walk test

    Participants will be asked to walk about 12 meters. The time taken to walk 10 meters will be recorded.

    Time frame: 10 weeks

  3. Berg balance Assessment

    This is a test that measures balance on a 5-point during routine tasks. The participant will be asked to perform 14 tasks involving: sitting, standing, reaching, lifting, and turning.

    Time frame: 10 weeks

  4. Fall Risk

    The silver index will be measured using the Hunova (Movendo Srl., Italy) to quantify the risk of falls. The Silver Index tasks include static balance while eyes are open or closed, dynamic balance while standing on passive and elastic surfaces, limits of stability, reactive balance during perturbations, 6-meter walk, and sit-to-stand.

    Time frame: 10 weeks

  5. Balance

    Root-mean-square of COM and COP displacements will be used to quantify balance tasks. COP will be obtained from Hunova. Whole body COM will be obtained using motion capture.

    Time frame: 10 weeks

  6. Temporal characteristics

    This test assesses deviations in timing of steps during walking.

    Time frame: 10 weeks

  7. Spatial characteristics

    This test assesses deviations in steplength during walking.

    Time frame: 10 weeks

  8. Physiological

    The participants will wear small sensors on their body to assess the activity of the brain and muscles during walking and balancing tasks.

    Time frame: 10 weeks

  9. Digit Span (Wechsler Adult Intelligence Scale [WAIS-IV])

    This test assesses attention and working memory.

    Time frame: 10 weeks

  10. Flanker Inhibitory Control and Attention Test

    This test assesses the allocation of limited attentional capacities to deal with an abundance of environmental stimulation. The test measures attention and the ability to inhibit response that may interfere with the ability to achieve goals.

    Time frame: 10 weeks

  11. Symbol Digit Modalities Test (SDMT)

    This test assesses processing speed without a motor component

    Time frame: 10 weeks

  12. Paced Auditory Serial Addition Test (PASAT)

    This test assesses information processing speed \& ability and working memory

    Time frame: 10 weeks

  13. Letter-Number Sequencing (WAIS-IV)

    This test assesses working memory

    Time frame: 10 weeks

  14. Delis-Kaplan Executive Function System

    Selected subtests to assess executive function.

    Time frame: 10 weeks

  15. Community Ambulation

    This test quantifies the amount of physical activity in the community using IMU sensors that participants will wear.

    Time frame: 10 weeks

  16. Continuous Performance Task

    This test assesses attention.

    Time frame: 10 weeks

  17. Magnetic Resonance Imaging (MRI)

    MRI scans will be performed to assess the structure and function of the brain while the participant is lying quietly in the MRI scanner.

    Time frame: 1 week

Secondary outcomes

  1. 6 Minute Walk Test

    Participants walk as far as possible for 6 minutes. They walk back and forth around the cones along an unobstructed pathway of 15 meters. They will be permitted to slow down or stop as necessary. The distance covered by the participant for the 6 minutes will be recorded at an interval of every 30 seconds using a measuring wheel and stop watch.

    Time frame: 10 weeks

  2. Dynamic Gait Index (DGI)

    DGI is a measurement tool commonly used to assess dynamic balance, gait and risk for falls29. It consists of a total of eight gait assessments which can be scored on a four-point ordinal scale, ranging from 0-3, where '0' indicates the lowest level of function and '3' the highest level of function, allowing for a total possible score of 24.

    Time frame: 10 weeks

07

Study locations

1 site
  • Kessler Foundation
    West Orange, New Jersey 07052, United States
    • Kiran Karunakaran, PhD · Contact · kirankarun@gmail.com · 551-358-3672
    • Kiran Karunakaran, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06719297
Lead sponsor
Kessler Foundation
Collaborators
Rutgers University, New Jersey Institute of Technology
Responsible party
Kiran Karunakaran (Research Scientist, Principal Investigator, Kessler Foundation) — Principal investigator
First posted
Dec 5, 2024
Start date
Dec 1, 2024 (estimated)
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Dec 5, 2024

Study contacts

Kiran Karunakaran, PhD
Contact
kirankarun@gmail.com
5513583672
Kiran Karunakaran
principal investigator · Kessler Foundation

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion